Brief: Revelation Biosciences Says Phase 1B Study In CKD Patients To Begin Early 2025

Revelation Biosciences

02/12/2024 11:16

Dec 2 (Reuters) - Revelation Biosciences Inc  REVB.O :
    * REVELATION BIOSCIENCES INC. ANNOUNCES FDA ACCEPTANCE OF
GEMINI
IND
    * REVELATION BIOSCIENCES INC -PHASE 1B STUDY IN CKD PATIENTS
TO
BEGIN EARLY 2025

Source text:  ID:nBw30H3Cca 
Further company coverage:  REVB.O 

 ((Reuters.Briefs@thomsonreuters.com;))